Helga Gleichmann

3.0k total citations
65 papers, 2.3k citations indexed

About

Helga Gleichmann is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Helga Gleichmann has authored 65 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 18 papers in Surgery and 16 papers in Genetics. Recurrent topics in Helga Gleichmann's work include Pancreatic function and diabetes (17 papers), Immune Cell Function and Interaction (14 papers) and Diabetes and associated disorders (13 papers). Helga Gleichmann is often cited by papers focused on Pancreatic function and diabetes (17 papers), Immune Cell Function and Interaction (14 papers) and Diabetes and associated disorders (13 papers). Helga Gleichmann collaborates with scholars based in Germany, Netherlands and United States. Helga Gleichmann's co-authors include Ernst Gleichmann, Zhiyong Wang, A G Rolink, G. F. Bottazzo, Steven T. Pals, Robert S. Schwartz, Gian Franco Bottazzo, Josef Abel, J André-Schwartz and Sabine Schulte im Walde and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Helga Gleichmann

63 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helga Gleichmann Germany 29 837 591 567 490 316 65 2.3k
Touhami Mahjoub Tunisia 29 582 0.7× 413 0.7× 249 0.4× 322 0.7× 446 1.4× 149 2.6k
P. Maderna Italy 28 890 1.1× 99 0.2× 643 1.1× 326 0.7× 289 0.9× 75 3.1k
D P Hajjar United States 28 651 0.8× 129 0.2× 805 1.4× 211 0.4× 173 0.5× 47 2.5k
Dilip K. Deb United States 31 586 0.7× 298 0.5× 281 0.5× 290 0.6× 203 0.6× 41 3.3k
Jakob Hendel Denmark 24 414 0.5× 402 0.7× 626 1.1× 115 0.2× 62 0.2× 85 1.8k
Orina Belton Ireland 25 597 0.7× 180 0.3× 434 0.8× 203 0.4× 285 0.9× 41 2.8k
Maryvonne Daveau France 28 562 0.7× 186 0.3× 351 0.6× 85 0.2× 233 0.7× 86 2.6k
G. A. Zimmerman United States 10 764 0.9× 86 0.1× 399 0.7× 123 0.3× 505 1.6× 11 2.3k
D. Neumeier Germany 23 723 0.9× 98 0.2× 373 0.7× 132 0.3× 187 0.6× 71 2.7k
Richard I. Rynes United States 20 576 0.7× 115 0.2× 371 0.7× 75 0.2× 247 0.8× 42 2.3k

Countries citing papers authored by Helga Gleichmann

Since Specialization
Citations

This map shows the geographic impact of Helga Gleichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Gleichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Gleichmann more than expected).

Fields of papers citing papers by Helga Gleichmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Gleichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Gleichmann. The network helps show where Helga Gleichmann may publish in the future.

Co-authorship network of co-authors of Helga Gleichmann

This figure shows the co-authorship network connecting the top 25 collaborators of Helga Gleichmann. A scholar is included among the top collaborators of Helga Gleichmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helga Gleichmann. Helga Gleichmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deerberg, F & Helga Gleichmann. (2015). The Occurrence of Spontaneous Immune-Complex Glomerulonephritis in Han: NMRI Mice. Contributions to nephrology. 19. 88–94.
3.
Walde, Sabine Schulte im, et al.. (2004). Differential Target Molecules for Toxicity Induced by Streptozotocin and Alloxan in Pancreatic Islets of Mice in Vitro. Experimental and Clinical Endocrinology & Diabetes. 112(1). 29–37. 29 indexed citations
4.
Gille, Lars, et al.. (2002). Generation of Hydroxyl Radicals Mediated by Streptozotocin in Pancreatic Islets of Mice in vitro. Pharmacology & Toxicology. 90(6). 317–326. 34 indexed citations
5.
Walde, Sabine Schulte im, et al.. (2002). Molecular target structures in alloxan-induced diabetes in mice. Life Sciences. 71(14). 1681–1694. 49 indexed citations
7.
Gleichmann, Helga, et al.. (1998). GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes. 47(1). 50–56. 38 indexed citations
8.
Gleichmann, Helga, et al.. (1990). Class II MHC antigens in vivo induced by the diabetogen streptozotocin in BALB/c mice. Journal of Autoimmunity. 3. 81–85. 3 indexed citations
9.
Gleichmann, Helga, et al.. (1989). T Cell-Dependent Class II Major Histocompatibility Complex Antigen Expression in vivo Induced by the Diabotegen Streptozotocin. Immunobiology. 180(1). 1–11. 7 indexed citations
10.
Gleichmann, Helga, Gian Franco Bottazzo, & F. A. Gries. (1988). Cytoplasmic Islet Cell Autoantibodies: Prevalence and Pathognomic Significance. Advances in experimental medicine and biology. 246. 71–77. 3 indexed citations
11.
Gleichmann, Helga & Gian Franco Bottazzo. (1987). Progress Toward Standardization of Cytoplasmic Islet Cell–Antibody Assay. Diabetes. 36(5). 578–584. 67 indexed citations
12.
Pals, Steven T., Helga Gleichmann, & Ernst Gleichmann. (1984). Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.. The Journal of Experimental Medicine. 159(2). 508–523. 22 indexed citations
13.
Pals, Steven T., et al.. (1983). GRAFT-VERSUS-HOST REACTIONS (GVHRS) - CLUES TO THE PATHOGENESIS OF A BROAD-SPECTRUM OF IMMUNOLOGICAL DISEASES. Pure Amsterdam UMC.
14.
Waal, Leo P. de, et al.. (1983). Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.. The Journal of Immunology. 130(2). 655–660. 14 indexed citations
15.
Gleichmann, Ernst, et al.. (1979). Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(4 Suppl). 708–23. 31 indexed citations
16.
Gleichmann, Ernst, et al.. (1976). Reactivation of radioresistant F1-specific parental cells by F1 T cells. Preliminary evidence for a semiallogeneic T-T cell interaction.. PubMed. 21(1). 77–81. 4 indexed citations
17.
Peters, Klaus, et al.. (1974). Genetic control of murine hemagglutinin formation to H-2.5. Immunogenetics. 1(1). 141–157. 3 indexed citations
18.
Gleichmann, Ernst & Helga Gleichmann. (1973). Immunosuppression and neoplasia. Journal of Molecular Medicine. 51(6). 260–265. 9 indexed citations
19.
Gleichmann, Helga, Ernst Gleichmann, J André-Schwartz, & Robert S. Schwartz. (1972). CHRONIC ALLOGENEIC DISEASE. The Journal of Experimental Medicine. 135(3). 516–532. 41 indexed citations
20.
Armstrong, Martine Y. K., Ernst Gleichmann, Helga Gleichmann, et al.. (1970). CHRONIC ALLOGENEIC DISEASE. The Journal of Experimental Medicine. 132(3). 417–439. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026